| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Janux Therapeutics, Inc. | Director | Common Stock | 6,250 | $159,750 | $25.56 | 11 Jun 2025 | Direct |
| eFFECTOR Therapeutics, Inc. | Chief Business Officer | Stock Option (Right to Buy) | 150,000 | 20 Jun 2022 | Direct | ||
| Janux Therapeutics, Inc. | Director | Stock Option (right to buy) | 11,667 | 11 Jun 2025 | Direct |